WENDELL WIERENGA

Profile

First Name

: WENDELL

Middle Name

:

Last Name

: WIERENGA

Related Companies
Titles
Company Name
Related People
DIRECTOR
XENOPORT INC
VINCENT J. ANGOTTI, RONALD W. BARRETT, GREGORY T. BATES, PAUL L. BERNS, GIANNA M. BOSKO, DENNIS M. FENTON, JOHN G. FREUND, CATHERINE J. FRIEDMAN, WILLIAM G. HARRIS, JERYL L. HILLEMAN, ERNEST MARIO, WILLIAM J. RIEFLIN, DAVID R. SAVELLO
DIRECTOR
CRINETICS PHARMACEUTICALS, INC.
CAMILLE BEDROSIAN, M.D., STEPHEN BETZ, STEPHEN F. BETZ, ROGERIO VIVALDI COELHO, M.D., CAREN DEARDORF, MASON FREEMAN, MASON FREEMAN, M.D., MATTHEW FUST, MATTHEW K. FUST, JAMES HASSARD, STEVE KALDOR, STEVE KALDOR, PH.D, JEFF KNIGHT, WESTON NICHOLS, PH.D, WESTON NICHOLS, PHD, JACK B. NIELSEN, STEPHANIE OKEY, DANA PIZZUTI, MAHENDRA SHAH, RICHARD SCOTT STRUTHERS, RICHARD SCOTT STRUTHERS, PH.D, RICHARD SCOTT STRUTHERS, PHD, WENDELL WIERENGA, PH.D, WENDELL WIERENGA, PHD, MARC WILSON, YUNFEI ZHU
DIRECTOR
APRICUS BIOSCIENCES, INC.
RICHARD BERMAN, CATHERINE BOVENIZER, EDWARD COX, ROBERTO CREA, MARGARET DALESANDRO, BASSAM B. DAMAJ, BRIAN DORSEY, JUDITH DUNN, HENRY J. ESBER, MICHAEL GOLEMBIEWSKI, BRIAN LIAN, VIVIAN LIU, PAUL V. MAIER, RAJ MEHRA, NEIL MORTON, DANIEL J. O-CONNOR, LEONARD A OPPENHEIM, LEONARD A. OPPENHEIM, RICHARD W. PASCOE, RUSTY RAY, ROBIN L. SMITH, SANDFORD D. SMITH, MARK WESTGATE, KLEANTHIS G. XANTHOPOULOS
DIRECTOR
DERMATA THERAPEUTICS, LLC
DAVID F. HALE, N/A HALE BIOPHARMA VENTURES, LLC, TOM INSLEY, CHRIS NARDO, GERALD T. PROEHL
DIRECTOR
DERMATA THERAPEUTICS, INC.
MARIA BEDOYA TORO MUNERA, BRITTANY BRADRICK, MARY FISHER, DAVID HALE, STEVEN J. MENTO, CHRISTOPHER J. NARDO, GERALD PROEHL, GERALD T. PROEHL, ANDREW SANDLER, KATHLEEN SCOTT, KYRI K. VAN HOOSE
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-01-07
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2025-12-29 
2025-02-04
D/A
Link
OTHER TECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2025-01-21 
2024-09-27
D
Link
OTHER TECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2024-09-17 
2023-06-12
D
Link
OTHER TECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2023-05-26 
2020-12-10
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2020-07-17 
2017-09-27
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2017-09-13 
2016-10-13
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2016-09-28 
2015-11-16
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-10-30 
2012-11-20
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
$25,000,001 - $100,000,000 
Equity 
2012-11-08